$1.31
0.05[3.97%]
At close: Apr 26
$1.31
0[0.00%]
After Hours: 7:56PM EDT
Clearside Biomedical
(NASDAQ:CLSD)Clearside Biomedical Stock (NASDAQ:CLSD), Insider Trading Activity
Clearside Biomedical: Insider buying and selling updated today.
Insider Shares Owned
6.481M
Insider Percentage Owned
8.67%
Institutional Shares Held
6.933M
Institutional Percentage Held
9.28%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Anthony Gibney | 100K | $1.30 | $129.66K | BUY | ∞ | 100K | Apr 17 - Apr 18 | View | |
| Mar 20, 2024 | Victor Hang Ngai Chong | CHIEF MEDICAL OFFICER | 30K | $1.60 | $48.00K | BUY | ∞ | 30K | Mar 20 | View |
| Feb 09, 2024 | Bradford T Whitmore | 10% OWNER | 444.444K | $1.35 | $600.00K | BUY | 6.94% | 6.845186M | Feb 07 | View |
| Jan 19, 2024 | GEORGE LASEZKAY | CEO | -18K | $1.27 | -$22.86K | SELL | -3.71% | 466.577K | Jan 19 | View |
| Jan 19, 2024 | Charles Deignan | CHIEF FINANCIAL OFFICER | -12.9K | $1.28 | -$16.51K | SELL | -3.24% | 384.662K | Jan 19 | View |
| Nov 01, 2023 | Bradford T Whitmore | 10% OWNER | 135.778K | $0.74 | $99.85K | BUY | 2.17% | 6.400742M | Oct 30 - Nov 01 | View |
| Oct 04, 2023 | Nancy Hutson | DIRECTOR | 10K | $0.86 | $8.60K | BUY | 12.05% | 93K | Oct 03 | View |
| Sep 25, 2023 | Clay Thorp | DIRECTOR | 10K | $0.86 | $8.60K | BUY | 0.28% | 3.585562M | Sep 25 | View |
| Jan 20, 2023 | Thomas Ciulla | CHIEF MEDICAL OFFICER | -13.7K | $1.47 | -$20.14K | SELL | -4.48% | 291.89K | Jan 20 | View |
| Jan 20, 2023 | GEORGE LASEZKAY | CEO | -20.03K | $1.46 | -$29.24K | SELL | -3.97% | 484.577K | Jan 19 | View |
| Jan 20, 2023 | Charles Deignan | CHIEF FINANCIAL OFFICER | -14.03K | $1.50 | -$21.05K | SELL | -3.72% | 363.472K | Jan 19 | View |
| Jan 11, 2023 | Thomas Ciulla | CHIEF MEDICAL OFFICER | -2.17K | $1.62 | -$3.52K | SELL | -0.71% | 305.59K | Jan 10 | View |
| Dec 21, 2022 | Clay Thorp | DIRECTOR | 14K | $1.02 | $14.27K | BUY | 0.39% | 3.575562M | Dec 21 | View |
| Nov 21, 2022 | Nancy Hutson | DIRECTOR | 30K | $1.33 | $39.90K | BUY | 56.60% | 83K | Nov 17 | View |
| Jan 20, 2022 | Charles Deignan | CHIEF FINANCIAL OFFICER | 34.917K | $2.09 | -$18.46K | GRANT | 11.03% | 351.366K | Jan 18 - Jan 19 | View |
| Jan 20, 2022 | Thomas Ciulla | CHIEF MEDICAL OFFICER | 34.7K | $2.13 | -$19.28K | GRANT | 13.32% | 295.26K | Jan 18 - Jan 19 | View |
| Jan 20, 2022 | GEORGE LASEZKAY | CEO | 86.7K | $2.12 | -$22.90K | GRANT | 20.75% | 504.607K | Jan 18 - Jan 19 | View |
| Jan 13, 2022 | GEORGE LASEZKAY | CEO | -5.1K | $2.46 | -$12.55K | SELL | -1.21% | 417.907K | Jan 11 | View |
| Sep 23, 2021 | Thomas Ciulla | CHIEF MEDICAL OFFICER | -2.56K | $6.40 | -$16.38K | SELL | -0.99% | 255.56K | Sep 21 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.